Posted on 07 November 2012.
Cipher Reports Strong Q3 2012 Financial Results
CIP-TRAMADOL ER (ConZip®/Durela®) Cipher's extended-release tramadol for the treatment of moderate to moderately severe chronic pain, was launched in the U.S. by Vertical Pharmaceuticals in September 2011 under the trade name ConZip®. Vertical's …
Full News here – Read more on Equities.com